Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

BIO Stock Forecast, Price Targets, Chart, Dividends & Analysis

Bio-Rad Laboratories Inc. Class A logo

Bio-Rad Laboratories Inc. Class A

Sector: Healthcare   

Industry: Diagnostics & Research

283.21
 
USD
  
6.05
  
(2.18%)
Previous close: 277.16  Open: 275.5  Bid: 285.68  Ask: 288.83
52 week range    
262.12   
   387.99
Mkt Cap: 8,811 M  Avg Vol (90 Days): 216,419
Last updated: Wednesday 19th February 2025
Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

BIO Income Statement

Annual
Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
Amortization of intangibles-36 M-35 M-31 M-28 M-23 M-27 M347 M406 M414 M411 M
Basic EPS from continuing operations142.33-121.79-21.82-65.36
Basic EPS total3.870.884.1212.2558.93127.86142.33-121.79-21.82-65.36
Basic weighted shares outstanding29 M29 M30 M30 M30 M30 M30 M30 M29 M28 M
Cost of sales898 M930 M972 M1,066 M1,055 M1,108 M1,284 M1,235 M1,244 M1,188 M
Depreciation-132 M-143 M-149 M-138 M-134 M-138 M138 M137 M146 M152 M
Depreciation unreconciled-40 M-37 M
DepreciationAndAmortization-132 M-143 M-149 M-138 M-40 M-37 M138 M137 M146 M152 M
Diluted EPS total3.850.884.0712.158.27126.2140.56-121.79-21.82-65.36
Diluted normalized net income/share140.56-121.79-21.82
Diluted weighted shares outstanding29 M30 M30 M30 M30 M30 M30 M30 M29 M28 M
GainOnSaleOfBusiness-400000.0-1 M-900000.01 M-1 M-2 M
GainOnSaleOfPPE-300000.0-600000.0-8 M5 M12 M1 M
GainOnSaleOfSecurity2 M800000.07 M606 M2,031 M4,496 M8 M2 M700000.07 M
GeneralAndAdministrativeExpense-45 M-44 M-44 M-47 M877 M828 M842 M814 M
Gross operating profit1,122 M1,138 M-972 M-1,066 M-1,055 M1,438 M1,638 M1,567 M1,427 M1,379 M
ImpairmentOfCapitalAssets62 M12 M293 M
Income before tax146 M42 M98 M513 M2,261 M4,908 M5,449 M-4,704 M-850 M-2,342 M
Income restructuring and M&A-12 M-11 M4 M28 M
Income taxes33 M16 M-24 M147 M502 M1,104 M1,195 M-1,077 M-213 M-498 M
InterestExpenseNonOperating22 M22 M23 M24 M23 M22 M2 M38 M49 M49 M
MiscOtherSpecialCharges11 M15 M2,171 M2,326 M2,338 M2,570 M27 M45 M106 M90 M
Net income from total operations113 M26 M122 M366 M1,759 M3,814 M4,254 M-3,628 M-637 M-1,844 M
NetIncomeCommonStockholders113 M26 M122 M366 M1,759 M3,814 M4,254 M-3,628 M-637 M-1,844 M
NetIncomeContinuousOperations113 M26 M122 M366 M1,759 M3,806 M4,254 M-3,628 M-637 M-1,844 M
NetNonOperatingInterestIncomeExpense-22 M-22 M-23 M-24 M-23 M-22 M-2 M-20 M-51 M-49 M
NonRecurringOperationExpense-141608.0-141608.0-141608.0-35 M
Normalized income-1,051 M-2,823 M
Operating income167 M115 M-2,029 M-2,100 M-2,082 M-2,135 M500 M483 M338 M269 M
Operating income before depreciation (EBITDA)168 M64 M121 M537 M2,244 M5,078 M5,588 M-4,529 M-655 M-2,142 M
OperatingExpense955 M1,023 M1,057 M1,034 M1,027 M1,027 M1,138 M1,092 M1,089 M1,110 M
Other income net-11 M-15 M-2,171 M-2,932 M-4,369 M-7,066 M-4,953 M-5,199 M-1,239 M2,567 M
OtherGandA-45 M-44 M-44 M-47 M877 M828 M842 M814 M
OtherImpairmentOfCapitalAssets-46 M-7 M-800000.0-6 M-5 M800000.012 M
OtherOperatingExpenses-1 M-3 M-35 M-5 M-51 M-45 M-18 M-10 M-12 M-6 M
OtherWriteOff-7 M-2 M-1 M-2 M-600000.05 M
RentAndLandingFees-45 M-44 M-44 M-47 M
Research & development expense193 M206 M250 M199 M203 M227 M261 M257 M247 M296 M
ResearchExpense193 M206 M250 M199 M203 M227 M261 M257 M247 M296 M
RestructringAndMnAIncome-12 M-11 M4 M28 M
Revenue per share-36 M-33 M-29 M-27 M-24 M-29 M346 M407 M414 M411 M
SalariesAndWages-17 M-20 M-23 M-28 M-36 M-42 M-7 M-9 M-10 M-11 M
Selling Gen & administrative expense762 M817 M807 M835 M825 M800 M877 M828 M842 M814 M
SellingAndMarketingExpense762 M817 M807 M835 M825 M800 M
SellingExpense762 M817 M807 M835 M825 M800 M
Special income/charges-62 M-12 M-293 M35 M11 M-4 M-28 M
Total Income available for interest expense (EBIT)168 M64 M121 M537 M2,284 M4,940 M5,451 M-4,666 M-801 M-2,294 M
Total common shares outstanding29 M30 M30 M30 M30 M30 M30 M30 M29 M28 M
Total net income113 M26 M122 M366 M1,759 M3,814 M4,254 M-3,628 M-637 M-1,844 M
Total ordinary shares23 M23 M23 M23 M23 M23 M23 M23 M23 M23 M
Total revenues2,019 M2,068 M2,160 M2,289 M2,312 M2,546 M2,923 M2,802 M2,671 M2,567 M
TotalExpenses1,853 M1,953 M2,029 M2,100 M2,082 M2,135 M2,422 M2,327 M2,333 M2,298 M
TotalRevenue2,019 M2,068 M2,160 M2,289 M2,312 M2,546 M2,923 M2,802 M2,671 M2,567 M
WriteDown-1 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader